College of Law > About > Events & CLE > Featured Events > Health Law Symposium > Past Symposia
Unplanned Obsolenscence: Reproductive Health Care Technology's Response to a Changing Legal Landscape
March 1, 2023
Each year, the Mary and Michael Jaharis Health Law Institute, in collaboration with the College of Law's Center for Intellectual Property Law & Information Technology (CIPLIT®), explores a critical legal issue at the intersection of health law, intellectual property law and information technology. Fittingly, this year’s symposium explores the seismic shift in the legal regulation of reproductive technologies and health services in the wake of the U.S. Supreme Court decision in Dobbs v Jackson Women’s Health.
Our interdisciplinary program brings together academics, legal practitioners and health care professionals to discuss these challenges and opportunities by taking an in-depth look at the wide-ranging legal effects and overall impact these radical changes will have on reproductive health care law going forward. The day will start with a discussion of the nuts and bolts of regulating contraceptive and abortion care, followed by a look at the legal and ethical responsibilities of reproductive medicine providers, and finally, the future of data privacy and research and development in the realm of reproductive health care.
To view the full agenda and list of presenters, click here.
Panel 1: Preempting Pregnancy: Federalism, Medication Abortion and Contraceptive Care
The U.S. Supreme Court majority opinion in Dobbs overturned decades of legal precedent, passing the power to regulate this component of reproductive health care to the states, creating a patchwork of differing laws across the country. In doing so, it generated a multitude of questions, particularly around the rights, responsibilities and liabilities of patients and providers seeking and providing medication, abortion and contraceptive care. Panelists will offer insights on how to make sense of the ongoing challenges and tensions between federal and state regulations, the use of technologies like telehealth and mail order prescriptions, the practical and equitable implications of limiting access to reproductive medicines, and the future of litigation surrounding reproductive care.
Panel 2: Fidelity in the Fertility Forum: Legal and Ethical Challenges in Fertility Medicine
The practice of fertility medicine is one of the primary fields utilizing modern reproductive health care technology. Advances in treatment options over the past decades, as well as jurisprudential changes, have introduced new complications to the ethical conflicts present at the heart of this area of medicine. This interdisciplinary panel will take a closer look at the real world legal and ethical responsibilities facing providers post-Dobbs and how the practice is evolving with new technological breakthroughs.
Featured Speaker: Radhika Rao, Professor of Law, UC College of the Law, San Francisco
The courts’ long history of regulating reproductive health care informs legal, policy and medical efforts to ensure equitable access to this medical care in the future. Professor Rao will discuss the future of reproductive rights following the U.S. Supreme Court decision in Dobbs through the historic lens of reproductive health care jurisprudence leading up to this moment. Her experiences clerking for Justices Blackmun and Marshall allow her to offer an insider’s perspective on Roe v. Wade’s viability framework and the role it played in structuring our current understanding of how to regulate reproductive technology. Her keynote will draw upon her extensive scholarship in the fields of abortion, assisted reproduction, cloning, stem cell research, genetic privacy, gene patenting and property rights in the human body.
Panel 3: Keeping the Personal Private: Data Privacy in Reproductive Health Care Technology
The proliferation of information technology for tracking, supporting and providing reproductive health treatment raises questions of how to balance the need for technology, especially when it facilitates greater access to care, with the need to protect private health information. Panelists will discuss who has access to this information, the ways in which individuals are unknowingly relinquishing their privacy rights and how third parties are using this data.
Panel 4: Research in the Reproductive Rights Unknown: The Future of Reproductive Research and Development
This interdisciplinary panel will look at how the Dobbs precedent already has affected how clinical research in reproductive health care is conducted and has influenced the development of new technologies. Panelists will discuss the need for inclusive and representative clinical trials within this new framework and the impact the decision has on future growth in this area.
DePaul College of Law is an accredited MCLE provider. This event is eligible for up to 7 CLE credit hours.
Access issues in health care are beginning to reach crisis point. Over the past decade, corporate interests have dictated structural changes in health care markets and consumers now face more barriers than ever when it comes to obtaining affordable, quality care. In response, the Biden Administration and the newly formed White House Competition Counsel are promoting more vigorous antitrust enforcement—scrutinizing actions taken by hospitals and drug companies in particular. This year’s symposium will explore how consolidation across health care markets has impacted access to care. Prominent legal scholars, antitrust enforcers, and expert practitioners will address a range of questions:
DePaul College of Law is an accredited MCLE provider, and this event is eligible for up to 7 CLE credit hours.
There are few spaces where rapid changes in technology impact our lives as profoundly as in the realm of healthcare. While advances in healthcare technologies signal immense progress for medicine and science, they also raise significant questions related to who has access to these innovations, and whether the advances are making us healthier as a whole.
COVID-19 has laid bare the structural barriers at the root of health disparities in the U.S. This year’s Jaharis Symposium centers on the premise that while technological advances have the potential to revolutionize the delivery of health care, they also raise significant questions about who has access to these innovations and whether they are advancing the interests of the populations with the greatest needs.
DePaul College of Law is an approve MCLE provider. This event is worth up to 5.75 general CLE hours.
Co-sponsored by the Mary and Michael Jaharis Health Law Institute and the Center for Intellectual Property Law & Information Technology (CIPLIT®).
Recent discoveries in the field of genetics herald immense innovation for medicine and science. However, they also raise significant questions related to individual privacy, societal uses of the information, and applications in the criminal justice system. For example, how should genetic information be controlled to ensure individual privacy and informed consent for all? What are the individual and societal implications of forensic uses of genetic record matching? How else should genetic information be used within the criminal justice system? Can genomic research ever be truly inclusive and representative of the diversity of our population
This 2020 interdisciplinary symposium addresses issues of distributive and procedural justice in genetics and genomics, as they relate to scientific innovation, intellectual property, human subjects research, and the criminal justice system.
“Democratizing” Medicine in a Data and Tech-Driven World.March 14, 2019
Technological and Emergency Responses to Pandemic Diseases
Telehealth: Transforming the Healthcare Delivery Landscape
The New Frontier of Health Innovation: Navigating the Regulatory Landscape
Designer Genes: The Cost of Genetic Information